Document is current
Any future updates will be listed below
-
Authors
,
Lam, Max https://orcid.org/0000-0002-4256-7844
,
,
Chen, Chia-Yen
Li, Zhiqiang https://orcid.org/0000-0002-0174-9254
Martin, Alicia R. https://orcid.org/0000-0003-0241-3522
Bryois, Julien https://orcid.org/0000-0002-4747-2166
Ma, Xixian
Gaspar, Helena https://orcid.org/0000-0002-5540-2707
Ikeda, Masashi
Benyamin, Beben https://orcid.org/0000-0001-5608-2293
Brown, Brielin C.
Liu, Ruize
Zhou, Wei
Guan, Lili
Kamatani, Yoichiro https://orcid.org/0000-0001-8748-5597
Kim, Sung-Wan
Kubo, Michiaki
Kusumawardhani, Agung A. A. A.
Liu, Chih-Min https://orcid.org/0000-0001-7016-8990
Ma, Hong
Periyasamy, Sathish https://orcid.org/0000-0002-8132-5717
Takahashi, Atsushi https://orcid.org/0000-0001-7099-8767
Xu, Zhida
Yu, Hao https://orcid.org/0000-0002-9785-8489
Zhu, Feng
Chen, Wei J.
Faraone, Stephen
Glatt, Stephen J.
He, Lin
Hyman, Steven E.
Hwu, Hai-Gwo
McCarroll, Steven A.
Neale, Benjamin M.
Sklar, Pamela
Wildenauer, Dieter B.
Yu, Xin
Zhang, Dai
Mowry, Bryan J.
Lee, Jimmy
Holmans, Peter
Xu, Shuhua
Sullivan, Patrick F.
Ripke, Stephan
O’Donovan, Michael C.
Daly, Mark J.
Qin, Shengying
Sham, Pak
Iwata, Nakao
Hong, Kyung S.
Schwab, Sibylle G. https://orcid.org/0000-0002-9370-9080
Yue, Weihua
Tsuang, Ming
Liu, Jianjun
Ma, Xiancang
Kahn, René S.
Shi, Yongyong
Huang, Hailiang
- License Information
-
More Information
Article History
Received: 9 January 2019
Accepted: 10 September 2019
First Online: 18 November 2019
Competing interests
: B.M.N. is a member of the Deep Genomics Scientific Advisory Board. He also serves as a consultant for the Camp4 Therapeutics Corporation, Takeda Pharmaceutical and Biogen. M.J.D. is a founder of Maze Therapeutics. The remaining authors declare no competing interests.
